58 related articles for article (PubMed ID: 16435157)
1. Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents.
Liu YL; Malik NM; Sanger GJ; Andrews PL
Cancer Chemother Pharmacol; 2006 Sep; 58(3):326-33. PubMed ID: 16435157
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin and functional dyspepsia.
Akamizu T; Iwakura H; Ariyasu H; Kangawa K
Int J Pept; 2010; 2010():. PubMed ID: 20721353
[TBL] [Abstract][Full Text] [Related]
3. Cachexia: A systemic consequence of progressive, unresolved disease.
Ferrer M; Anthony TG; Ayres JS; Biffi G; Brown JC; Caan BJ; Cespedes Feliciano EM; Coll AP; Dunne RF; Goncalves MD; Grethlein J; Heymsfield SB; Hui S; Jamal-Hanjani M; Lam JM; Lewis DY; McCandlish D; Mustian KM; O'Rahilly S; Perrimon N; White EP; Janowitz T
Cell; 2023 Apr; 186(9):1824-1845. PubMed ID: 37116469
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment with Empagliflozin ameliorates Cisplatin induced acute kidney injury by suppressing apoptosis.
Abd Elmaaboud MA; Kabel AM; Elrashidy M
J Appl Biomed; 2019 Mar; 17(1):90. PubMed ID: 34907751
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin and Glucagon-Like Peptide-1: A Gut-Brain Axis Battle for Food Reward.
Decarie-Spain L; Kanoski SE
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803053
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine Administration Reduces Chemotherapy-Induced Nausea Behavior in Rats.
Jaime-Lara RB; Borner T; Holland RA; Shaulson E; Brooks B; De Jonghe BC
Biol Res Nurs; 2021 Oct; 23(4):584-595. PubMed ID: 33789505
[TBL] [Abstract][Full Text] [Related]
7. Natural ghrelin in advanced cancer patients with cachexia, a case series.
Blum D; de Wolf-Linder S; Oberholzer R; Brändle M; Hundsberger T; Strasser F
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):506-516. PubMed ID: 33452750
[TBL] [Abstract][Full Text] [Related]
8. The Benefits of Olanzapine in Palliating Symptoms.
Davis MP; Sanger GJ
Curr Treat Options Oncol; 2020 Nov; 22(1):5. PubMed ID: 33244634
[TBL] [Abstract][Full Text] [Related]
9. Peripherally administered cisplatin activates a parvocellular neuronal subtype expressing arginine vasopressin and enhanced green fluorescent protein in the paraventricular nucleus of a transgenic rat.
Akiyama Y; Yoshimura M; Ueno H; Sanada K; Tanaka K; Sonoda S; Nishimura H; Nishimura K; Motojima Y; Saito R; Maruyama T; Hirata K; Uezono Y; Ueta Y
J Physiol Sci; 2020 Jul; 70(1):35. PubMed ID: 32650712
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.
Brierley DI; Harman JR; Giallourou N; Leishman E; Roashan AE; Mellows BAD; Bradshaw HB; Swann JR; Patel K; Whalley BJ; Williams CM
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):844-859. PubMed ID: 31035309
[TBL] [Abstract][Full Text] [Related]
11. Arcuate Nucleus Orexin-A Signaling Alleviates Cisplatin-Induced Nausea and Vomiting Through the Paraventricular Nucleus of the Hypothalamus in Rats.
Guo F; Gao S; Xu L; Sun X; Zhang N; Gong Y; Luan X
Front Physiol; 2018; 9():1811. PubMed ID: 30618823
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of D-Methionine on Body Weight Loss, Anorexia, and Nephrotoxicity in Cisplatin-Induced Chronic Toxicity in Rats.
Lin MT; Ko JL; Liu TC; Chao PT; Ou CC
Integr Cancer Ther; 2018 Sep; 17(3):813-824. PubMed ID: 29430988
[TBL] [Abstract][Full Text] [Related]
13. Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials.
Harada T; Amano T; Ikari T; Takamura K; Ogi T; Fujikane T; Fujita Y; Taima K; Tanaka H; Sasaki T; Okumura S; Sugawara S; Yokouchi H; Yamada N; Morikawa N; Dosaka-Akita H; Isobe H; Nishimura M
Front Pharmacol; 2017; 8():972. PubMed ID: 29387008
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Targeting the Ghrelin Pathway.
Colldén G; Tschöp MH; Müller TD
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398233
[TBL] [Abstract][Full Text] [Related]
15. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.
Bresciani E; Rizzi L; Molteni L; Ravelli M; Liantonio A; Ben Haj Salah K; Fehrentz JA; Martinez J; Omeljaniuk RJ; Biagini G; Locatelli V; Torsello A
Endocrine; 2017 Oct; 58(1):106-114. PubMed ID: 27896546
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.
Sanger GJ; Furness JB
Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):38-48. PubMed ID: 26392067
[TBL] [Abstract][Full Text] [Related]
17. Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans.
Farmer AD; Ban VF; Coen SJ; Sanger GJ; Barker GJ; Gresty MA; Giampietro VP; Williams SC; Webb DL; Hellström PM; Andrews PL; Aziz Q
J Physiol; 2015 Mar; 593(5):1183-96. PubMed ID: 25557265
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the various phases of cisplatin-induced emesis in rats.
Shi J
Oncol Lett; 2014 Nov; 8(5):2017-2022. PubMed ID: 25289087
[TBL] [Abstract][Full Text] [Related]
19. Changes in plasma ghrelin and serum leptin levels after Cisplatin-based transcatheter arterial infusion chemotherapy for hepatocellular carcinoma.
Matsumura T; Arai M; Yoshikawa M; Sudo K; Nakamura K; Katsuno T; Kanai F; Yamaguchi T; Yokosuka O
ISRN Gastroenterol; 2013; 2013():415450. PubMed ID: 23533792
[TBL] [Abstract][Full Text] [Related]
20. Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function.
Sung EZ; Arasaradnam RP; Jarvie EM; James S; Goodyear SJ; Borman RA; Snead D; Sanger GJ; Nwokolo CU
Mol Biol Rep; 2012 Dec; 39(12):9989-94. PubMed ID: 22744429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
